MHC-I in the hippocampus promotes comorbid depressive symptoms in bone cancer pain via the upregulation of microglial TREM2/DAP12 signaling.

MLA

Li, Xiaohui, et al. “MHC-I in the Hippocampus Promotes Comorbid Depressive Symptoms in Bone Cancer Pain via the Upregulation of Microglial TREM2/DAP12 Signaling.” Behavioural Brain Research, vol. 461, Mar. 2024, p. 114843. EBSCOhost, https://doi.org/10.1016/j.bbr.2023.114843.

APA

Li, X., Jia, Y., Xiong, M., Gao, Y., Xu, X., & Ke, C. (2024). MHC-I in the hippocampus promotes comorbid depressive symptoms in bone cancer pain via the upregulation of microglial TREM2/DAP12 signaling. Behavioural Brain Research, 461, 114843. https://doi.org/10.1016/j.bbr.2023.114843

Chicago

Li, Xiaohui, Yifu Jia, Mengyuan Xiong, Yan Gao, Xueqin Xu, and Changbin Ke. 2024. “MHC-I in the Hippocampus Promotes Comorbid Depressive Symptoms in Bone Cancer Pain via the Upregulation of Microglial TREM2/DAP12 Signaling.” Behavioural Brain Research 461 (March): 114843. doi:10.1016/j.bbr.2023.114843.